Recurrent lymphoid and myeloid relapses due to treatment cessations reveal natural history of Ph-positive B-ALL and pose a diagnostic challenge.

Autor: Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jabbour EJ; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hu CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jazyk: angličtina
Zdroj: American journal of hematology [Am J Hematol] 2024 Apr; Vol. 99 (4), pp. 721-726. Date of Electronic Publication: 2024 Jan 19.
DOI: 10.1002/ajh.27210
Databáze: MEDLINE